April 30, 2025 (MLN): Highnoon Laboratories Restricted (PSX: HINOON) reported a revenue after tax of Rs954.56 million for the primary quarter ended 31 March 2025, reflecting an 18% improve in comparison with Rs809.02m in SPLY.
The pharmaceutical firm’s income rose 14% year-on-year to Rs7.03 billion from Rs6.14bn, pushed by stronger buyer contracts.
Gross revenue surged 22% to Rs3.68bn, whereas the price of gross sales climbed 7% to Rs3.34bn.
Working revenue elevated 26% to Rs1.34bn, regardless of increased bills throughout key segments.
Distribution, promoting, and promotional bills jumped 20% to Rs1.87bn, whereas administrative and basic bills rose 24% to Rs330.44m.
Analysis and improvement spending greater than tripled to Rs17.16m.
Different revenue grew by 36% to Rs97.83m, offsetting a 40% spike in finance prices to Rs27.76m.
The corporate additionally incurred a levy of Rs4.84m through the quarter. Taxation rose sharply by 46% to Rs451.79m.
Earnings per share (EPS) for the interval stood at Rs18.02, up from Rs15.27 in Q1 2024.
| Condensed interim consolidated assertion of revenue and loss for the primary quarter ended 31 March 2025 (in Rupees) | 2025 | 2024 | %Change |
| Income from contracts with prospects – internet | 7,025,898,202 | 6,141,870,352 | 14% |
| Price of gross sales | (3,342,282,703) | (3,118,635,482) | 7% |
| Gross revenue | 3,683,615,499 | 3,023,234,870 | 22% |
| Distribution, promoting and promotional bills | (1,874,627,715) | (1,556,935,464) | 20% |
| Administrative and basic bills | (330,442,883) | (265,676,308) | 24% |
| Analysis and improvement bills | (17,160,193) | (5,660,704) | 203% |
| Different working bills | (120,269,365) | (127,575,036) | -6% |
| Working revenue | 1,341,115,343 | 1,067,387,358 | 26% |
| Different revenue | 97,833,917 | 71,917,975 | 36% |
| Finance prices | (27,757,244) | (19,859,822) | 40% |
| Revenue earlier than revenue tax and levy | 1,411,192,016 | 1,119,445,511 | 26% |
| Levy | (4,838,674) | – | |
| Revenue earlier than revenue tax | 1,406,353,342 | 1,119,445,511 | 26% |
| Taxation | (451,789,185) | (310,421,298) | 46% |
| Revenue after tax for the interval | 954,564,157 | 809,024,213 | 18% |
| Earnings per share – fundamental and diluted | 18.02 | 15.27 |
Copyright Mettis Hyperlink Information
Posted on: 2025-04-30T15:18:30+05:00
The put up Highnoon Laboratories posts Rs954.56m Q1 revenue, up 18% YoY appeared first on Mettis International Hyperlink.
#Highnoon #Laboratories #posts #Rs95456m #revenue #YoY
Leave a Reply